PE20080233A1 - Suspension acuosa estable antiinflamatoria - Google Patents

Suspension acuosa estable antiinflamatoria

Info

Publication number
PE20080233A1
PE20080233A1 PE2007000600A PE2007000600A PE20080233A1 PE 20080233 A1 PE20080233 A1 PE 20080233A1 PE 2007000600 A PE2007000600 A PE 2007000600A PE 2007000600 A PE2007000600 A PE 2007000600A PE 20080233 A1 PE20080233 A1 PE 20080233A1
Authority
PE
Peru
Prior art keywords
suspension
inflammatory
amount
sweeteners
aqueous suspension
Prior art date
Application number
PE2007000600A
Other languages
English (en)
Inventor
Lillian Cromie
Willy Blakely
Louise Reynolds
Original Assignee
Norbrook Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38170964&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20080233(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0610058A external-priority patent/GB0610058D0/en
Priority claimed from GB0610246A external-priority patent/GB0610246D0/en
Application filed by Norbrook Lab Ltd filed Critical Norbrook Lab Ltd
Publication of PE20080233A1 publication Critical patent/PE20080233A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

REFERIDA UNA SUSPENSION FARMACEUTICA ACUOSA QUE COMPRENDE: UN FARMACO ANTIINFLAMATORIO NO ESTEROIDEO, UN SISTEMA TAMPONANTE ACUOSO, GOMA XANTANO EN UNA CANTIDAD DE 0,4% p/v DE LA SUSPENSION, POLIVINILPIRROLIDONA EN UNA CANTIDAD DE ENTRE 1% Y 2,2% p/v DE LA SUSPENSION, GLICEROL EN UNA CANTIDAD DE ENTRE 10% Y 30% p/v DE LA SUSPENSION Y AGENTES MODIFICADORES DEL SABOR TALES COMO EDULCORANTES DE CARGA, EDULCORANTES INTENSOS, AGENTES SABORIZANTES Y MEZCLAS DE ELLOS, DONDE DICHA SUSPENSION CARECE DE ALMIDON PREGELATINIZADO, ACIDO AMINO POLICARBOXILICO, CELULOSA MICROCRISTALINA, HIDROXIPROPILMETILCELULOSA, MONOOLEATO DE POLIOXIETILEN SORBITAN Y DIOXIDO DE SILICIO. DENTRO DE LOS FARMACOS ANTIINFLAMATORIOS SE ENCUENTRAN OXICAMS, ACIDOS FENAMICOS, SALICILATOS, DERIVADOS DEL ACIDO PROPIONICO, ENTRE OTROS, DE PREFERENCIA SON PIROXICAM, MELOXICAM, CARPROFENO E IBUPROFENO. DICHA SUSPENSION ES UTIL EN EL TRATAMIENTO DE ENFERMEDADES INFLAMATORIAS E INFECCIOSAS
PE2007000600A 2006-05-19 2007-05-17 Suspension acuosa estable antiinflamatoria PE20080233A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0610058A GB0610058D0 (en) 2006-05-19 2006-05-19 Stable aqueous suspension
GB0610246A GB0610246D0 (en) 2006-05-23 2006-05-23 Stable aqueous suspension
GB0708375A GB2438287A (en) 2006-05-19 2007-04-30 Stable aqueous suspension

Publications (1)

Publication Number Publication Date
PE20080233A1 true PE20080233A1 (es) 2008-04-10

Family

ID=38170964

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000600A PE20080233A1 (es) 2006-05-19 2007-05-17 Suspension acuosa estable antiinflamatoria

Country Status (16)

Country Link
US (1) US9399013B2 (es)
JP (2) JP5391063B2 (es)
KR (1) KR101452721B1 (es)
AT (1) ATE446740T1 (es)
CR (1) CR10429A (es)
DE (1) DE602007003026D1 (es)
DK (1) DK2034958T3 (es)
EA (1) EA015301B1 (es)
ES (1) ES2335622T3 (es)
GB (1) GB2438287A (es)
IL (1) IL194244A (es)
MX (1) MX2008011775A (es)
NZ (1) NZ572380A (es)
PE (1) PE20080233A1 (es)
PT (1) PT2034958E (es)
SI (1) SI2034958T1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6050564B2 (ja) * 2010-03-11 2016-12-21 テイカ製薬株式会社 フィルム状製剤
GB201117858D0 (en) * 2011-10-17 2011-11-30 Norbrook Lab Ltd Paste
FI126442B (en) * 2011-11-01 2016-12-15 Valio Oy Liquid enzyme preparation and process for its preparation
WO2019037757A1 (zh) * 2017-08-24 2019-02-28 江苏恒瑞医药股份有限公司 一种包含美洛昔康的可注射的药物组合物及其制备方法
KR102145022B1 (ko) * 2018-08-14 2020-08-14 동아제약 주식회사 이부프로펜의 현탁액 조성물 및 투여 제형
US20210093642A1 (en) * 2019-09-26 2021-04-01 Cadila Healthcare Limited STABLE AQUEOUS PARENTERAL SOLUTIONS OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs)

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2756113A1 (de) 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
NZ234143A (en) 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
CA2033634A1 (en) 1990-01-12 1991-07-13 Takao Ikariya Method of manufacturing aromatic urethane
JPH0714872B2 (ja) * 1990-02-06 1995-02-22 昭和薬品化工株式会社 シロップ剤組成物
US5183829A (en) 1991-09-27 1993-02-02 Applied Analytical Industries, Inc. Oral liquid compositions of non-steroidal anti-inflammatory drugs
US5272137A (en) 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
KR940003066A (ko) 1992-07-07 1994-02-19 김주용 콘택홀 접속방법
CA2121435C (en) 1993-04-16 2002-01-22 Sheila M. Ratnaraj Aqueous pharmaceutical suspension and process for preparation thereof
ES2322405T3 (es) * 1996-07-08 2009-06-19 Penwest Pharmaceuticals Co. Matriz de liberacion controlada para farmacos insolubles en dosis elevadas.
IT1286496B1 (it) 1996-11-20 1998-07-15 Leetrim Ltd Dublin Composizione farmaceutica orale ad attivita' antipiretica,analgesica ed antiinfiammatoria
JP4234666B2 (ja) * 1997-03-28 2009-03-04 エーザイ・アール・アンド・ディー・マネジメント株式会社 苦味等を隠蔽した経口薬剤
EP0945131A1 (de) 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Perorale Wirkstoff-Suspension
US6184220B1 (en) 1998-03-27 2001-02-06 Boehringer Ingelheim Pharma Kg Oral suspension of pharmaceutical substance
US6268356B1 (en) 1998-04-20 2001-07-31 Pharmaceutical Resources, Inc. Flocculated suspension of megestrol acetate
JP4073121B2 (ja) * 1998-08-28 2008-04-09 エーザイ・アール・アンド・ディー・マネジメント株式会社 薬物の苦味等を軽減した組成物
JP2000119198A (ja) * 1998-10-16 2000-04-25 Eisai Co Ltd 苦味等の隠蔽されたホスフォジエステラーゼ阻害剤含有経口製剤
EP1165042B1 (fr) 1999-04-06 2005-02-02 Ethypharm Suspension pharmaceutique buvable d'ibuprofene
US7101572B2 (en) 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
WO2003105804A1 (en) 2002-06-17 2003-12-24 Taro Pharmaceuticals U.S.A, Inc. Ibuprofen suspension
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
US20050069590A1 (en) * 2003-09-30 2005-03-31 Buehler Gail K. Stable suspensions for medicinal dosages
PL1824493T3 (pl) * 2004-12-06 2009-01-30 Janssen Pharmaceutica Nv Zawiesina zawierająca meloksykam do podawania doustnego

Also Published As

Publication number Publication date
KR20090023607A (ko) 2009-03-05
DE602007003026D1 (de) 2009-12-10
GB0708375D0 (en) 2007-06-06
IL194244A (en) 2011-12-29
US20090186883A1 (en) 2009-07-23
EA015301B1 (ru) 2011-06-30
KR101452721B1 (ko) 2014-10-21
JP5391063B2 (ja) 2014-01-15
MX2008011775A (es) 2008-10-01
US9399013B2 (en) 2016-07-26
DK2034958T3 (da) 2010-03-15
SI2034958T1 (sl) 2010-02-26
ATE446740T1 (de) 2009-11-15
JP2009537495A (ja) 2009-10-29
EA200870546A1 (ru) 2009-04-28
CR10429A (es) 2008-12-01
GB2438287A (en) 2007-11-21
ES2335622T3 (es) 2010-03-30
PT2034958E (pt) 2010-01-04
NZ572380A (en) 2011-10-28
JP2013241422A (ja) 2013-12-05

Similar Documents

Publication Publication Date Title
AR061011A1 (es) Suspension acuosa estable
PE20080233A1 (es) Suspension acuosa estable antiinflamatoria
AR087210A2 (es) Formulacion farmaceutica de la sal sodica del telmisartan
CY1116599T1 (el) Φαρμακευτικες συνθεσεις ελεγχομενης απελευθερωσης που περιλαμβανουν εστερα φουμαρικου οξεος
EA200870219A1 (ru) Стабилизированные сукцинатом витамина е фармацевтические композиции, способы их получения и применения
AR057422A1 (es) Uan composicion farmaceutica de liberacion modificada, proceso de preparacion de dicha composicion y metodo para emplear la misma
DE60032749D1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
DK1317419T3 (da) Cyanophenoxycarboxylsyre-forbindelser og sammensætninger til at levere aktive midler
TW200600121A (en) Pharmaceutical dosage forms
CL2011003371A1 (es) Composicion farmaceutica de dosis fija, oral, solida y estable que comprende irbesartan, besilato de amlodipino y excipientes; procedimientos de preparacion; uso en el tratamiento de la hipertension.
JP5966228B2 (ja) アリピプラゾール組成物
CO6270217A2 (es) Formulaciones galenicas de alisquireno y valsartan
AR079409A1 (es) Preparaciones antihelminticas granuladas y sistemas de suninistros
EP2540294A4 (en) SOLID PREPARATION WITH DELAYED RELEASE FOR ORAL ADMINISTRATION
KR20090057400A (ko) 트롬빈 수용체 길항제의 동결건조된 신속 붕해성 경구 제형
ATE526012T1 (de) Pharmazeutische formulierungen von meloxicam
NO20083183L (no) Fast farmasoytisk sammensetning inneholdende irbesartan
MA29922B1 (fr) NOUVEAUX DERIVES DE BENZIMIDAZOLES ET BENZOTHIAZOLES, LEUR PROCEDE DE PREPARATION, LEUR APPLICATION A TITRE DE MEDICAMENTS, COMPOSITIONS PHARMACEUTIQUES ET NOUVELLE UTILISATION NOTAMMENT COMME INHIBITEURS DE CMet
AR062925A1 (es) Metodo para fabricar tabletas que contienen agentes farmacologicamente activos
NO20082140L (no) Fremgangsmate til fremstilling av kandesartancileksetil
NO20064298L (no) Piperazinureaderivater til behandling av endometriose
TR200301553A1 (tr) İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar
DK2252263T3 (da) Galenisk form til oral transmukosal indgivelse af triptaner
CL2010000738A1 (es) Suspension farmaceutica oral que comprende desde 100 hasta 500 mg/5ml de paracetamol, desde 40 hasta 80 mg/5ml de ibuprofeno o desde 200 hasta 400 mg/5ml de paracetamol, desde 100 hasta 200 mg/5ml de ibuprofeno y uno o mas excipientes farmaceuticamente aceptables, util para tratar el dolor pre, peri o postoperatorio.

Legal Events

Date Code Title Description
FD Application declared void or lapsed